Bioptimus Raises $76M for Its “GPT of Biology” Technology
Bioptimus, an emerging biotech company, has secured $76 million in its latest funding round to accelerate the development of its groundbreaking platform—dubbed the “GPT of…
Bioptimus, an emerging biotech company, has secured $76 million in its latest funding round to accelerate the development of its groundbreaking platform—dubbed the “GPT of…
Archive Intel, an innovative provider of AI-driven compliance solutions, has successfully raised $1.5 million in funding to accelerate the growth of its cutting-edge technology. The…
Tome Biosciences made its public debut on Tuesday, armed with a substantial $213 million in funding from prominent investors and technology licensed from the Massachusetts…
Healionics, a Seattle-based medical technology startup, has raised an additional $5.5 million in funding, representing a major advancement in the field of dialysis treatment for…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.